Ellen Puré

24.3k total citations · 5 hit papers
173 papers, 15.4k citations indexed

About

Ellen Puré is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Ellen Puré has authored 173 papers receiving a total of 15.4k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Immunology, 66 papers in Molecular Biology and 54 papers in Oncology. Recurrent topics in Ellen Puré's work include Cell Adhesion Molecules Research (35 papers), Proteoglycans and glycosaminoglycans research (31 papers) and T-cell and B-cell Immunology (28 papers). Ellen Puré is often cited by papers focused on Cell Adhesion Molecules Research (35 papers), Proteoglycans and glycosaminoglycans research (31 papers) and T-cell and B-cell Immunology (28 papers). Ellen Puré collaborates with scholars based in United States, Germany and Poland. Ellen Puré's co-authors include Daniel J. Rader, Carolyn A. Cuff, Steven Μ. Albelda, Richard K. Assoian, Robert L. Camp, Peter C. Isakson, James Monslow, Albert Lo, Joanna Cichy and E S Vitetta and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ellen Puré

172 papers receiving 15.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

2008 800 citations Qihong Huang, Kiranmai Gumireddy et al. profile →
Resolution of Lung Inflammation by CD44

2002 552 citations Priit Teder, R. William Vandivier et al. Science profile →
Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity

2013 515 citations Liang‐Chuan S. Wang, Albert Lo et al. Cancer Immunology Research profile →
Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells

2015 407 citations Albert Lo, Liang‐Chuan S. Wang et al. Cancer Research profile →
Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors

2023 129 citations Zebin Xiao, Leslie Todd et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ellen Puré	5.5k	5.1k	4.4k	2.6k	2.4k	173	15.4k
Peter J. Polverini	9.9k 1.8×	4.2k 0.8×	6.1k 1.4×	1.6k 0.6×	3.8k 1.6×	146	20.4k
Hellmut G. Augustin	11.0k 2.0×	2.7k 0.5×	4.3k 1.0×	2.0k 0.8×	3.4k 1.4×	206	19.0k
Brian J. Nickoloff	5.3k 1.0×	9.1k 1.8×	4.4k 1.0×	1.8k 0.7×	1.4k 0.6×	239	19.0k
Marco Presta	11.0k 2.0×	2.9k 0.6×	2.3k 0.5×	3.4k 1.3×	3.0k 1.2×	330	17.4k
Shigeki Higashiyama	8.2k 1.5×	2.1k 0.4×	4.4k 1.0×	2.6k 1.0×	2.0k 0.8×	279	15.6k
Jonathan P. Sleeman	7.3k 1.3×	2.1k 0.4×	4.7k 1.1×	3.1k 1.2×	2.3k 1.0×	167	13.1k
Jeremy Saklatvala	6.9k 1.3×	3.6k 0.7×	2.8k 0.6×	1.3k 0.5×	2.8k 1.1×	154	14.0k
Elaine W. Raines	10.4k 1.9×	5.2k 1.0×	3.1k 0.7×	2.5k 1.0×	3.4k 1.4×	142	23.3k
Masayuki Miyasaka	6.0k 1.1×	8.8k 1.7×	2.6k 0.6×	2.5k 1.0×	1.1k 0.5×	370	19.3k
Jennifer R. Gamble	6.0k 1.1×	4.8k 0.9×	1.3k 0.3×	1.6k 0.6×	1.5k 0.6×	157	14.4k

Countries citing papers authored by Ellen Puré

Since Specialization

Citations

This map shows the geographic impact of Ellen Puré's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Puré with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Puré more than expected).

Fields of papers citing papers by Ellen Puré

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Puré. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Puré. The network helps show where Ellen Puré may publish in the future.

Co-authorship network of co-authors of Ellen Puré

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Puré. A scholar is included among the top collaborators of Ellen Puré based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Puré. Ellen Puré is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhong, Wenqun, Zebin Xiao, Ziyan Yu, et al.. (2023). Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors. Cancer Research. 83(16). 2790–2806. 39 indexed citations

Clifton, Guy T., Mace L. Rothenberg, Paolo A. Ascierto, et al.. (2023). Developing a definition of immune exclusion in cancer: results of a modified Delphi workshop. Journal for ImmunoTherapy of Cancer. 11(6). e006773–e006773. 21 indexed citations

Noguera-Ortega, Estela, Zebin Xiao, Leslie Todd, et al.. (2022). Monitoring Therapeutic Response to Anti-FAP CAR T Cells Using [18F]AlF-FAPI-74. Clinical Cancer Research. 28(24). 5330–5342. 34 indexed citations

Espinet, Elisa, Lukas Klein, Ellen Puré, & Shiv K. Singh. (2022). Mechanisms of PDAC subtype heterogeneity and therapy response. Trends in cancer. 8(12). 1060–1071. 37 indexed citations

Cho, Christina, Amy R. Peck, Yunguang Sun, et al.. (2020). Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesis. Oncogene. 39(38). 6129–6137. 19 indexed citations

Monslow, James, et al.. (2020). Fibroblast Activation Protein Regulates Lesion Burden and the Fibroinflammatory Response in Apoe-Deficient Mice in a Sexually Dimorphic Manner. American Journal Of Pathology. 190(5). 1118–1136. 15 indexed citations

Barrett, Richard, Jaewon Kim, Diana Avery, et al.. (2019). Deletion of Calcineurin Promotes a Protumorigenic Fibroblast Phenotype. Cancer Research. 79(15). 3928–3939. 6 indexed citations

Cremasco, Viviana, Jillian L. Astarita, Angelo L. Grauel, et al.. (2018). FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors. Cancer Immunology Research. 6(12). 1472–1485. 147 indexed citations

Avery, Diana, Priya Govindaraju, Michele H. Jacob, et al.. (2017). Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts. Matrix Biology. 67. 90–106. 151 indexed citations

10.

Newick, Kheng, Shaun O’Brien, Jing Sun, et al.. (2016). Augmentation of CAR T-cell Trafficking and Antitumor Efficacy by Blocking Protein Kinase A Localization. Cancer Immunology Research. 4(6). 541–551. 160 indexed citations

11.

Wang, Enxiu, Liang-Chuan Wang, Ching‐Yi Tsai, et al.. (2015). Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors. Cancer Immunology Research. 3(7). 815–826. 91 indexed citations

12.

Lo, Albert, Liang‐Chuan S. Wang, John Scholler, et al.. (2015). Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells. Cancer Research. 75(14). 2800–2810. 407 indexed citations breakdown →

13.

Moon, Edmund K., Liang-Chuan Wang, Douglas V. Dolfi, et al.. (2014). Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors. Clinical Cancer Research. 20(16). 4262–4273. 344 indexed citations

14.

Licciulli, Silvia, Jacqueline L. Avila, Linda Hanlon, et al.. (2013). Notch1 Is Required for Kras-Induced Lung Adenocarcinoma and Controls Tumor Cell Survival via p53. Cancer Research. 73(19). 5974–5984. 93 indexed citations

15.

Eisinger‐Mathason, T.S. Karin, Minsi Zhang, Qiong Qiu, et al.. (2013). Hypoxia-Dependent Modification of Collagen Networks Promotes Sarcoma Metastasis. Cancer Discovery. 3(10). 1190–1205. 213 indexed citations

16.

Tchou, Julia, Panpan Zhang, Yue Bi, et al.. (2011). P1-03-09: Significance of FAP, SMA and CD31 Expression in the Stroma of Breast Cancer.. Cancer Research. 71(24_Supplement). P1–3. 1 indexed citations

17.

Huang, Qihong, Kiranmai Gumireddy, Mariëtte Schrier, et al.. (2008). The micrornas mir-373 and mir-520c promote tumor migration, invasion and metastasis. Cancer Research. 68. 5015–5015. 1 indexed citations

18.

Sague, Sarah, Cristina M. Tato, Ellen Puré, & Christopher A. Hunter. (2004). The Regulation and Activation of CD44 by Natural Killer (NK) Cells and Its Role in the Production of IFN-γ. Journal of Interferon & Cytokine Research. 24(5). 301–309. 34 indexed citations

19.

Teder, Priit, R. William Vandivier, Dianhua Jiang, et al.. (2002). Resolution of Lung Inflammation by CD44. Science. 296(5565). 155–158. 552 indexed citations breakdown →

20.

Cuff, Carolyn A., Devashish Kothapalli, Sam Chun, et al.. (2001). The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. Journal of Clinical Investigation. 108(7). 1031–1040. 257 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact